The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...

These tests have very limited clinical use. The need for antibody testing would be to determine if a patient has recovered from COVID-19, and whether we could take a sample of the patient’s plasma to ...

A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...

H1N1 influenza cases are rising across India, with Delhi and Karnataka among the places reporting a sharp increase in ...

Please provide your email address to receive an email when new articles are posted on . Whole blood PCR testing was more effective than plasma for detecting West Nile virus. Cerebrospinal fluid PCR ...

Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "PCR and Realtime PCR Testing Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering. The global ...

The U.S. Centers for Disease Control and Prevention (CDC) currently doesn’t have a polymerase chain reaction, or PCR, test to detect the Andes strain of the hantavirus in patients, as 10 people who ...

A new diagnostic tool developed by researchers can test for SARS-CoV-2 and Zika virus with the same or better accuracy as high-precision PCR tests in a matter of hours. Over the past four years, many ...